Crucially, this Kv1.3 upregulation played a significant role in neuroinflammation-mediated neurodegeneration in the MitoPark and MPTP in vivo parkinsonism models that were ameliorated upon PAP-1 administration100. Here, KCNA3 is linked to Parkinson disease.